Flow Forward Medical
This Fairway, Kansas company was a contest runner-up for its novel approach to rapidly establish high-quality vascular access sites for hemodialysis in children with end-stage kidney disease.
The Arteriovenous Fistula Eligibility (AFE) system is a small, temporary, external blood pump designed to stimulate flow-mediated dilation to make more patients eligible for an arteriovenous fistula (AVF) and increase success rates after surgery, according to the company’s website. Establishment of a reliable AVF reduces morbidity and mortality in hemodialysis patients, as well as the overall cost of care.